Environmental variations in endophthalmitis
3 August 2023
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
Endophthalmitis, anti-VEGF, climate, intravitreal injection, season
In this retrospective cohort study, the authors looked at seasonal and environmental variations in 171 endophthalmitis cases out of 423,297 intravitreal injections. The incidence of this complication was not correlated to monthly snowfall, rainfall, or average temperature. There was no...
OCT prognostic factors in AMD patients with peripapillary choroidal neovascularisation
3 August 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this retrospective study the authors aimed to investigate the correlation between optical coherence tomography (OCT) findings and visual acuity outcomes after treatment with intravitreal bevacizumab (IVB) injections for age-related macular degeneration (AMD) patients with peripapillary choroidal neovascularisation (PPCNV). Data...
Glaucoma medications and ocular surface disease
3 August 2023
| Su Young
|
EYE - Glaucoma
|
Drug allergy, OSD, drug toxicity, drug-induced cicatricial keratitis, dry eye, glaucoma medications, ocular surface disease
This literature review examined ocular surface disease (OSD) associated with glaucoma medication. The authors examined the prevalence of features and management guidelines glaucoma medication associated OSD. Fifty-eight articles published within the past five years are included in this review and...
Local surgical treatment of trigeminal neuralgia
This is a retrospective review of a new surgical treatment of intractable periorbital neuropathic pain. Five patients with post-herpetic (three), post-traumatic (one) and idiopathic (one) neuralgia underwent transection of the nerves supplying the dermatomes affected by the neuropathic pain. The...
Symfony and vivity: comparing two EDOF IOLs
This prospective, randomised, double-masked, single-surgeon study compared the visual outcome between two commonly used extended depth of focus (EDOF) lenses, the Tecnis Symfony IOL (Johnson & Johnson Vision) and the Acrysof IQ Vivity IOL (Alcon Laboratories, Inc.). Sixty-nine patients underwent...
Patients prefer vision from lasik than from smile in a contralateral-eye trial
This prospective, randomised, single surgeon, contralateral-eye clinical trial compared the results in myopic patients undergoing wavefront-guided femtosecond laser in situ keratomileusis (LASIK) in one eye and small-incision lenticule extraction (SMILE) in the fellow eye. The patient-reported outcomes with laser in...
High rate of conversion from ocular hypertension (OH) to glaucoma (UG) in subjects with uveitis
5 June 2023
| Jonathan Chan
|
EYE - Glaucoma
|
glaucoma, infection, inflammation, treatment medical, treatment surgery
This is a retrospective study from Auckland over a 10-year period including 188 eyes of 139 subjects with either OH or UG and were included for analysis with a mean follow-up of 9.9 years. The most common uveitis causes were...
Use of international interocular difference thresholds for optic neuritis diagnosis in clinical practice
5 June 2023
| Claire Howard
|
EYE - Neuro-ophthalmology
|
AQP4, MOG, MOGAD, Multiple sclerosis, NMOSD, optical coherence tomography
Multiple sclerosis (MS) is the most common non-traumatic cause of disability in young people, and visual symptoms can be the initial manifestation in up to 20% of cases. Retinal examination can be helpful in making the correct diagnosis. The latest...
Malpractice from telephone triage in ophthalmology
5 June 2023
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Litigation malpractice, Telephone, dermatology, telemedicine, triage
The authors examined malpractice lawsuits related to ophthalmology telemedicine telephone triage in the US. The study reviewed a total of 510 lawsuits and identified 18 cases that involved synchronous telephone visits, while none involved video telecommunication. The study found that...
Narrative review of opsoclonus myoclonus ataxia syndrome following COVID-19
5 June 2023
| Claire Howard
|
EYE - Neuro-ophthalmology
|
COVID-19, SARS-CoV-2, complications, myoclonus, neuro-COVID, opsoclonus
Opsoclonus myoclonus syndrome (OMS) / opsoclonus myoclonus ataxia syndrome (OMAS) is a rare central nervous system manifestation of COVID-19, but an increasing number of articles have reported patients in whom COVID-19 was complicated by OMS / OMAS. This narrative review...
Electrocautery and implantable cardiac devices
This is a literature review of the risks associated with bipolar and monopolar electrocautery in patients with a permanent pacemaker (PPM) or implantable cardioverter defibrillator (ICD). The authors found 12 publications which met their inclusion criteria, but within these there...
Incomplete teprotumumab treatment for thyroid eye disease
This is a multi-centre retrospective analysis of clinical outcomes in patients who were on teprotumumab for thyroid eye disease but had the usual regime of eight infusions, three weeks apart, interrupted due to COVID-19. Manufacturing was suspended between Dec 2020...
